Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: CHINA

Sector: Pharmaceutical Retailers

Categories: @china   

111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription, and other services. 111 serves patients in China.
Website: yaoex.com


  • Bad financial results growth rate -46.8% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (7.3%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield -10.5% (LTM)
  • Share price is 6.2% higher than minimum and 91.7% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (500.0x vs 30.0x)

Key Financials (Download financials)

Ticker: YI
Share price, USD:  (+2.0%)1.03
year average price 2.1248  


year start price 2.7261 2023-04-30

max close price 3.3377 2023-07-21

min close price 0.9701 2024-04-17

current price 1.0300 2024-04-29
Common stocks: 83 355 454

Dividend Yield:  0.0%
Last revenue growth (y/y):  -3.7%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  25.3%
Historical growth of EBITDA:  -10.7%
EV / Sales: 0.1x
Margin (EBITDA LTM / Revenue): -1.4%

Target EV / EBITDA (hist percentile): 30.0x
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 86
Net Debt ($m): 70
EV (Enterprise Value): 156
EBITDA LTM (млн $): -30
Price to Book: -1.1x
Latest review:

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-03-21Seeking Alpha

111, Inc. (YI) Q4 2023 Earnings Call Transcript

2024-03-01PRNewsWire

111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow

2023-11-13PRNewsWire

111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow

2023-05-25PRNewsWire

111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol YI YI YI YI YI YI YI
reportedCurrency CNY CNY CNY CNY CNY CNY CNY
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2023-12-31 2023-11-30 2023-06-15 2023-03-23 2023-04-28 2022-09-30 2022-06-30
acceptedDate 2023-12-30 19:00:00 2023-11-30 06:04:34 2023-06-15 06:47:39 2023-03-23 06:03:23 2023-04-28 06:18:03 2022-09-29 20:00:00 2022-06-29 20:00:00
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3 Q2
revenue 4 109M 3 665M 3 477M 3 697M 4 148M 3 349M 3 037M
costOfRevenue 3 996M 3 475M 3 270M 3 461M 3 895M 3 147M 2 845M
grossProfit 113M 191M 208M 236M 253M 202M 192M
grossProfitRatio 0.027 0.052 0.060 0.064 0.061 0.060 0.063
researchAndDevelopmentExpenses 49M 25M 25M 0 0 0 0
generalAndAdministrativeExpenses 98M 46M 39M 169M 229M 176M 160M
sellingAndMarketingExpenses 174M 96M 90M 89M 134M 108M 101M
sellingGeneralAndAdministrativeExpenses 271M 141M 129M 259M 363M 284M 261M
otherExpenses 0 38 000 1M -578 000 -1M -976 000 10M
operatingExpenses 315M 271M 249M 258M 362M 283M 272M
costAndExpenses 4 310M 3 746M 3 519M 3 718M 4 257M 3 429M 3 117M
interestIncome 3M 2M 2M 2M 2M 3M 1M
interestExpense 0 5M 5M 4M 3M 4M 3M
depreciationAndAmortization 10M 2M 4M 5M 5M 4M 0
ebitda -196M -78M -38M -17M -103M -77M -92M
ebitdaratio -0.048 -0.021 -0.011 -0.005 -0.025 -0.023 -0.030
operatingIncome -207M -80M -41M -22M -108M -81M -80M
operatingIncomeRatio -0.050 -0.022 -0.012 -0.006 -0.026 -0.024 -0.026
totalOtherIncomeExpensesNet 1M 117 000 -1M 2M 4M -6M -5M
incomeBeforeTax -205M -83M -45M -19M -104M -86M -85M
incomeBeforeTaxRatio -0.050 -0.023 -0.013 -0.005 -0.025 -0.026 -0.028
incomeTaxExpense 149 000 102 000 14M 6M 3M 12M 0
netIncome -210M -93M -57M -25M -107M -98M -95M
netIncomeRatio -0.051 -0.025 -0.016 -0.007 -0.026 -0.029 -0.031
eps -2.480 -1.100 -0.680 -0.300 -1.290 -1.180 -2.280
epsdiluted -2.480 -1.100 -0.680 -0.300 -1.290 -1.180 -2.280
weightedAverageShsOut 85M 85M 84M 84M 83M 83M 83M
weightedAverageShsOutDil 85M 85M 84M 84M 83M 83M 83M
link Link Link Link Link
finalLink Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol YI YI YI YI YI YI YI
reportedCurrency CNY CNY CNY CNY CNY CNY CNY
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2023-12-31 2023-11-30 2023-06-15 2023-03-23 2023-04-28 2022-09-30 2022-06-30
acceptedDate 2023-12-30 19:00:00 2023-11-30 06:04:34 2023-06-15 06:47:39 2023-03-23 06:03:23 2023-04-28 06:18:03 2022-09-29 20:00:00 2022-06-29 20:00:00
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 604M 731M 576M 585M 674M 721M 666M
shortTermInvestments 50M 110M 123M 259M 206M 107M 205M
cashAndShortTermInvestments 654M 841M 699M 844M 880M 827M 871M
netReceivables 614M 656M 516M 481M 532M 496M 523M
inventory 1 419M 1 481M 1 388M 1 468M 1 499M 1 241M 1 224M
otherCurrentAssets 246M 180M 193M 226M 282M 227M 198M
totalCurrentAssets 2 933M 3 195M 2 832M 3 020M 3 236M 2 792M 2 816M
propertyPlantEquipmentNet 138M 147M 192M 194M 212M 237M 262M
goodwill 0 0 0 0 0 0 0
intangibleAssets 2M 2M 3M 0 3M 0 0
goodwillAndIntangibleAssets 2M 2M 3M 3M 3M 4M 4M
longTermInvestments 2M 2M 2M 2M 2M 2M 2M
taxAssets 0 0 0 0 0 0 0
otherNonCurrentAssets 13M 14M 21M 20M 20M 20M 21M
totalNonCurrentAssets 156M 166M 218M 219M 238M 263M 288M
otherAssets 0 0 0 0 0 0 0
totalAssets 3 089M 3 361M 3 050M 3 239M 3 474M 3 055M 3 104M
accountPayables 1 589M 1 815M 1 513M 1 681M 1 765M 1 548M 1 511M
shortTermDebt 338M 349M 310M 270M 179M 230M 259M
taxPayables 0 0 0 0 38M 0 0
deferredRevenue 0 0 0 0 324M 0 0
otherCurrentLiabilities 848M 817M 498M 550M 458M 481M 479M
totalCurrentLiabilities 2 774M 2 981M 2 321M 2 501M 2 725M 2 258M 2 248M
longTermDebt 63M 65M 89M 86M 100M 115M 129M
deferredRevenueNonCurrent 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0
otherNonCurrentLiabilities 5M 0 0 0 0 -113 000 437 000
totalNonCurrentLiabilities 68M 65M 89M 86M 100M 115M 129M
otherLiabilities 0 0 0 0 0 0 0
capitalLeaseObligations 63M 65M 89M 86M 100M 115M 129M
totalLiabilities 2 842M 3 046M 2 409M 2 587M 2 826M 2 373M 2 377M
preferredStock 0 0 0 0 0 0 0
commonStock 57 000 57 000 57 000 56 000 56 000 56 000 56 000
retainedEarnings -3 819M -3 609M -3 516M -3 458M -3 427M -3 312M -3 215M
accumulatedOtherComprehensiveIncomeLoss 73M 80M 82M 73M 76M 79M 69M
othertotalStockholdersEquity 3 163M 3 015M 2 988M 2 962M 2 936M 2 863M 2 831M
totalStockholdersEquity -583M -513M -446M -423M -415M -371M -315M
totalEquity 247M 315M 641M 652M -415M -371M -315M
totalLiabilitiesAndStockholdersEquity 3 089M 3 361M 3 050M 3 239M 3 474M 3 055M 2 062M
minorityInterest 830M 829M 1 087M 1 075M 1 063M 1 052M 0
totalLiabilitiesAndTotalEquity 3 089M 3 361M 3 050M 3 239M 3 474M 3 055M 2 062M
totalInvestments 52M 112M 125M 261M 208M 109M 207M
totalDebt 401M 414M 398M 356M 279M 345M 388M
netDebt -203M -317M -178M -229M -394M -376M -278M
link Link Link Link Link
finalLink Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol YI YI YI YI YI YI YI
reportedCurrency CNY CNY CNY CNY CNY CNY CNY
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2023-12-31 2023-11-30 2023-06-15 2023-03-23 2023-04-28 2022-09-30 2022-06-30
acceptedDate 2023-12-30 19:00:00 2023-11-30 06:04:34 2023-06-15 06:47:39 2023-03-23 06:03:23 2023-04-28 06:18:03 2022-09-29 20:00:00 2022-06-29 20:00:00
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3 Q2
netIncome -210M -93M -57M 0 -266M -98M 0
depreciationAndAmortization 0 0 0 0 41M 0 0
deferredIncomeTax 0 0 0 0 0 0 0
stockBasedCompensation 151M 26M 24M 0 162M 0 0
changeInWorkingCapital 0 0 0 0 359M 0 0
accountsReceivables 0 0 0 0 -87M 0 0
inventory 0 0 0 0 28M 0 0
accountsPayables 0 0 0 0 417M 0 0
otherWorkingCapital 0 0 0 0 -359M 0 0
otherNonCashItems -138M 102M 10M 0 -233M 110M -30M
netCashProvidedByOperatingActivities -197M 35M -23M -121M 63M 12M -30M
investmentsInPropertyPlantAndEquipment 0 0 0 0 -32M 0 0
acquisitionsNet 0 0 0 0 0 0 0
purchasesOfInvestments 0 0 0 0 -1 269M 0 0
salesMaturitiesOfInvestments 0 0 0 0 1 259M 0 0
otherInvestingActivites 60M 5M 19M 0 -77M 100M -52M
netCashUsedForInvestingActivites 60M 5M 19M -53M -118M 100M -52M
debtRepayment 0 0 0 0 0 0 0
commonStockIssued 0 0 0 0 274 000 0 0
commonStockRepurchased 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0
otherFinancingActivites 2M 110M 2M 0 22M -41M 6M
netCashUsedProvidedByFinancingActivities 2M 110M 2M 78M 22M -41M 6M
effectOfForexChangesOnCash -7M 3M 329 000 -1M -9M 7M 7M
netChangeInCash -143M 153M -898 000 -98M -42M 79M -69M
cashAtEndOfPeriod 624M 766M 85M 619M 717M 759M 681M
cashAtBeginningOfPeriod 766M 613M 85M 717M 759M 681M 750M
operatingCashFlow -197M 35M -23M -121M 63M 12M -30M
capitalExpenditure 0 0 0 0 -32M 0 0
freeCashFlow -197M 35M -23M -121M 32M 12M -30M
link Link Link Link Link
finalLink Link Link Link Link

Earning call transcript

2023 q4
2024-03-21 ET (fiscal 2023 q4)
2023 q3
2023-11-30 ET (fiscal 2023 q3)
2023 q2
2023-08-24 ET (fiscal 2023 q2)
2022 q4
2023-03-24 ET (fiscal 2022 q4)
2022 q3
2022-12-01 ET (fiscal 2022 q3)
2022 q2
2022-08-25 ET (fiscal 2022 q2)
2022 q1
2022-06-16 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-03-21 08:47 ET
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
2024-03-01 09:00 ET
111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow
2024-02-27 13:58 ET
111 Announces Receipt of Withdrawal of Going Private Proposal
2023-11-30 06:00 ET
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results
2023-11-13 05:10 ET
111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow
2023-08-24 06:00 ET
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results
2023-07-31 09:59 ET
111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow
2023-06-15 05:22 ET
111, Inc. Announces First Quarter 2023 Unaudited Financial Results
2023-05-25 06:05 ET
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow
2023-03-23 06:17 ET
111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results
2023-03-02 07:35 ET
111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow
2023-02-16 05:33 ET
111, Inc. Hosts Hua Medicine Launches First Official Flagship Store
2022-12-01 07:33 ET
111, Inc. Announces Third Quarter 2022 Unaudited Financial Results
2022-11-08 06:09 ET
111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow
2022-09-23 04:30 ET
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
2022-09-09 09:53 ET
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
2022-08-25 06:18 ET
111, Inc. Announces Second Quarter 2022 Unaudited Financial Results
2022-08-05 06:26 ET
111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 - Conference Call to Follow
2022-06-16 07:58 ET
111, Inc. Announces First Quarter 2022 Unaudited Financial Results
2022-05-26 08:59 ET
111 to Announce First Quarter 2022 Unaudited Financial Results on June 16, 2022 - Conference Call to Follow
2022-05-05 09:18 ET
111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act
2022-04-13 09:02 ET
111, Inc. Provides Urgently-needed Items and Online Services to Support Shanghai's Fight Against Covid-19 Pandemic
2022-03-17 07:20 ET
111, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results
2022-03-14 11:35 ET
111, Inc. Becomes First Online Retail Platform for BGI's SARS-CoV-2 Virus Antigen Detection Kits
2022-03-04 09:24 ET
111, Inc. Reaches Strategic Partnership on Direct Supply with Beilin Pharmaceutical to Blaze New Trails in Digital Development of Chinese Patent Medicine
2022-02-22 08:38 ET
111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow
2021-11-19 05:31 ET
111, Inc. Announces Third Quarter 2021 Unaudited Financial Results
2021-10-28 23:00 ET
/C O R R E C T I O N -- 111, Inc./
2021-10-25 11:00 ET
111, Inc. Announces Strategic Partnership with Chugai Pharma China Co., Ltd. to Accelerate Innovations in Chronic Disease Management
2021-09-17 11:00 ET
111, Inc. Announces Participation in the Cantor Virtual Global Healthcare Conference
2021-09-07 09:00 ET
111, Inc. Announces $10 Million Share Repurchase Program
2021-08-27 06:30 ET
111, Inc. Announces Second Quarter 2021 Unaudited Financial Results
2021-08-16 12:00 ET
111, Inc. Deepens Partnership with Bayer Healthcare
2021-08-09 11:30 ET
111 to Announce Second Quarter 2021 Unaudited Financial Results on August 27, 2021 -Conference Call to Follow
2021-08-03 12:00 ET
111, Inc. Enters into Strategic Cooperation Agreement with Zelgen to Develop a New Management Platform for Liver Cancer Patients in China
2021-05-19 06:17 ET
111, Inc. Announces First Quarter 2021 Unaudited Financial Results
2021-04-21 12:00 ET
111 to Announce First Quarter 2021 Unaudited Financial Results on May 19, 2021 - Conference Call to Follow
2021-03-25 09:00 ET
111 Signs Strategic Cooperation Agreement with Jianming Pharmaceutical to Develop Chronic Disease Management Platform
2021-03-18 10:10 ET
111, Inc. Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results
2021-03-16 09:40 ET
111, Inc. Achieves Full Distribution Coverage Across Mainland China with the Opening of Two Key Fulfillment Centers
2021-02-25 11:00 ET
111 to Announce Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results on March 18, 2021
2021-02-05 11:00 ET
111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services
2020-12-22 09:22 ET
111, Inc. Announces Additional Round of New Capital Injection
2020-11-19 10:00 ET
111, Inc. Announces Third Quarter 2020 Unaudited Financial Results
2020-10-22 10:00 ET
111 to Announce Third Quarter 2020 Unaudited Financial Results on November 19, 2020
2020-10-19 10:50 ET
111, Inc. Teams Up with Bayer Healthcare to Explore the Vast Blue Ocean of Online Healthcare
2020-10-15 21:40 ET
111, Inc. Teams Up with Huluwa Pharmaceutical to Explore the New Domain of "Internet + pharmaceutical"
2020-10-15 21:35 ET
111 to be the Omni-channel Drug Commercialization Partner of Xiangxu Pharmaceutical for Traditional Chinese Medicine

SEC forms

Show financial reports only

SEC form 6
2024-03-21 06:55 ET
Yi Technology published news for 2023 q4
SEC form 6
2024-03-21 06:55 ET
Yi Technology reported for 2023 q4
SEC form 6
2024-02-27 07:05 ET
Yi Technology published news for 2023 q4
SEC form 6
2024-02-27 07:05 ET
Yi Technology published news for 2023 q4
SEC form 6
2023-11-30 06:04 ET
Yi Technology reported for 2023 q3
SEC form 6
2023-08-24 06:10 ET
Yi Technology reported for 2023 q2
SEC form 6
2023-06-15 06:47 ET
Yi Technology reported for 2023 q1
SEC form 6
2023-04-28 06:18 ET
Yi Technology published news for 2023 q1
SEC form 6
2023-03-23 06:03 ET
Yi Technology published news for 2022 q4
SEC form 6
2022-12-01 06:09 ET
Yi Technology published news for 2022 q3
SEC form 6
2022-09-23 06:05 ET
Yi Technology published news for 2022 q2
SEC form 6
2022-09-09 06:13 ET
Yi Technology published news for 2022 q2
SEC form 6
2022-08-25 06:04 ET
Yi Technology published news for 2022 q2
SEC form 6
2022-06-16 06:02 ET
Yi Technology published news for 2022 q1
SEC form 6
2022-05-05 07:56 ET
Yi Technology published news for 2022 q1
SEC form 6
2022-04-29 06:54 ET
Yi Technology published news for 2022 q1
SEC form 6
2022-03-17 06:49 ET
Yi Technology published news for 2021 q4
SEC form 6
2022-03-01 06:16 ET
Yi Technology published news for 2021 q4
SEC form 6
2021-11-19 06:02 ET
Yi Technology published news for 2021 q3
SEC form 6
2021-09-07 06:36 ET
Yi Technology published news for 2021 q2
SEC form 6
2021-08-27 06:02 ET
Yi Technology published news for 2021 q2
SEC form 6
2021-05-19 07:39 ET
Yi Technology published news for 2021 q1
SEC form 6
2021-04-30 06:05 ET
Yi Technology published news for 2021 q1
SEC form 6
2021-03-18 08:34 ET
Yi Technology published news for 2020 q4
SEC form 6
2020-12-22 06:06 ET
Yi Technology published news for 2020 q3
SEC form 6
2020-11-19 06:31 ET
Yi Technology published news for 2020 q3
SEC form 6
2020-11-06 06:01 ET
Yi Technology published news for 2020 q3